Subscribe To
Service properties trust: high dividend but balance sheet a concern
Service Properties Trust is a REIT with a hotel portfolio and a net lease portfolio, offering a high dividend yield of 9.69%. The company has a high l...
June 25, 2023, 7:03 am
1 low-risk financial stock that's crushed the market
Visa stock has crushed the market since going public. The company has a dominant position in the paymen...
June 25, 2023, 6:20 am
Abb ltd: strong margins pave the way for buybacks
ABB Ltd has been able to diversify revenues efficiently and grow its topline at a good rate. Several megatrends are pushing demand towards ABBNY and t...
June 25, 2023, 6:13 am
Sprouts: capitalize on an emerging organic american diet
Sprouts Farmers Market offers a compelling investment opportunity due to its focus on healthy foods and strong financial performance, with potential f...
June 25, 2023, 5:17 am
Banc of california: reducing the earnings estimate due to the top line
I've reduced my earnings estimate as I've slashed both my loan balance and margin estimates following t...
June 24, 2023, 10:33 pm
Cot stock market charts: weekly speculator changes led by s&p500-mini & vix
By InvestMacro Here are the latest charts and statistics for the Commitment of Traders (COT) data publishe...
June 24, 2023, 8:08 pm
Cot bonds charts: speculators raised fed funds and sofr 3-months bets this week
By InvestMacro Here are the latest charts and statistics for the Commitment of Traders (COT) reports data publi...
June 24, 2023, 8:01 pm
Prigozhin to leave for belarus, case against him to be dropped
The Kremlin says Yevgeny Prigozhin will leave for Belarus is a deal that was brokered by Belarusian President Alexander Luka...
June 24, 2023, 8:00 pm
Copper speculators raise their bets into first bullish position in 9 weeks
By InvestMacro Here are the latest charts and statistics for the Commitment of Traders (COT) data publishe...
June 24, 2023, 6:55 pm
British pound speculators sharply boosted bullish bets on boe rate hike
By InvestMacro Here are the latest charts and statistics for the Commitment of Traders (COT) data publishe...
June 24, 2023, 6:22 pm
Prigozhin says convoys returning to bases
Wagner leader Yevgeny Prigozhin said he gave the order to return convoys headed to Moscow back to their bases in order to avoid blood...
June 24, 2023, 5:41 pm
Earnings watch: q2 profits are set for their biggest drop since the pandemic, but then the worst may be over for the year
Wall Street is expecting a third straight quarter of declining profits when second-quarter earnings reports are publi...
June 24, 2023, 5:19 pm
Corn speculators push their bullish bets sharply higher on drought
By InvestMacro Here are the latest charts and statistics for the Commitment of Traders (COT) reports data publi...
June 24, 2023, 4:08 pm
89bio publishes positive results from phase 2 entrigue trial of pegozafermin in patients with severe hypertriglyceridemia (shtg) in nature medicine
– Published data showed consistent and significant reductions in triglycerides, atherogenic lipoprote...
June 24, 2023, 9:05 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am
Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...
June 24, 2023, 9:01 am